Clinical Trials Logo

Clinical Trial Summary

The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.


Clinical Trial Description

This was a randomized, double-blind, multicenter, vehicle-controlled, parallel-group study in subjects with active head lice infestation. The study was designed to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to scalp and hair for 10 minutes at home.

Approximately 106 index subjects with their household members were enrolled into the study. A total of approximately 318 subjects were enrolled, assuming an average of 3 members per household participating in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02060903
Study type Interventional
Source Dr. Reddy's Laboratories Limited
Contact
Status Completed
Phase Phase 3
Start date February 2014
Completion date August 2014

See also
  Status Clinical Trial Phase
Completed NCT02097485 - Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation Phase 2
Recruiting NCT04878276 - Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Completed NCT01907490 - Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation Phase 2
Completed NCT02062060 - Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Phase 3
Recruiting NCT06057506 - Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation N/A
Completed NCT02010333 - A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation Phase 2